\
&
Contact us
\
&
Contact us
Published on | 5 months ago
Programmes HealthThe European Partnership on Rare Diseases (ERDERA) has opened its first Joint Transnational Call for Proposals on 'Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation'. The timeline of the call is as follows:
Research Foundation Flanders (FWO) participates in this call. More information on available funding for researchers based in Flanders and on who can apply & how is specified in the call documents. Questions? Please contact europe@fwo.be .
Projects should address at least two of the following:
Please note, certain approaches, including ATMP therapies and clinical trials, are excluded from this call. Detailed eligibility criteria are outlined in the Call Guidelines.
More information is available on the ERDERA website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The ROOT project obtained funding under Horizon 2020 topic ‘EGNSS applications fostering societal resilience and protecting the environment’. The project, which ran from November 2020 to July 2022, aimed to demonstrate the benefit of Galileo OSNMA signal to increase the robustness of critical telecom infrastructures.
The Flanders-based company Septentrio contributed substantially to completing this objective together with the other ROOT partners. The results of the project partially close a gap in the security of telecommunication networks dependent on satellite-derived time, with indirect benefits in curbing illegal attempts to disrupt network services.
